HLS Therapeutics Inc (HLS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HLS Therapeutics Inc (HLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8150
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HLS Therapeutics Inc (HLS Therapeutics) is a pharmaceutical company that offers central nervous system and cardiovascular therapeutic products. The company’s product includes clozaril, absorica, vascepa and trinomial. Its clozapine is a pharmaceutical product used in the treatment of schizophrenia. HLS Therapeutics offers novel therapies. The company offers services such as acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products. The company has its operations in Canada, Barbados and the US. HLS Therapeutics is headquartered in Toronto, Ontario, Canada.

HLS Therapeutics Inc (HLS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
HLS Therapeutics Acquires Rights to Clozaril 10
Venture Financing 11
HLS Therapeutics Raises USD30 Million in Venture Financing 11
HLS Therapeutics Raises USD112.8 Million in Venture Financing 12
Partnerships 13
Amarin and HLS Therapeutics Enter into Agreement 13
Merger 14
HLS Therapeutics and Automodular Complete Merger 14
HLS Therapeutics Inc – Key Competitors 16
HLS Therapeutics Inc – Key Employees 17
HLS Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 15, 2018: HLS Therapeutics Announces Q2 2018 Financial Results 19
May 16, 2018: HLS Therapeutics Announces Q1 2018 Financial Results 22
Mar 29, 2018: HLS Therapeutics Reports Fiscal 2017 Financial Results 24
Corporate Communications 26
Mar 16, 2018: HLS Therapeutics Opens Market 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HLS Therapeutics Acquires Rights to Clozaril 10
HLS Therapeutics Raises USD30 Million in Venture Financing 11
HLS Therapeutics Raises USD112.8 Million in Venture Financing 12
Amarin and HLS Therapeutics Enter into Agreement 13
HLS Therapeutics and Automodular Complete Merger 14
HLS Therapeutics Inc, Key Competitors 16
HLS Therapeutics Inc, Key Employees 17
HLS Therapeutics Inc, Other Locations 18
HLS Therapeutics Inc, Subsidiaries 18

List of Figures
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HLS Therapeutics Inc (HLS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sun Pharmaceutical Industries Ltd:企業のM&A・事業提携・投資動向
    Sun Pharmaceutical Industries Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sun Pharmaceutical Industries Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • The Norwegian Radium Hospital Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary The Norwegian Radium Hospital Research Foundation (RF) is a healthcare research hospital that provides clinical studies. The hospital conducts research programs and clinical studies. It offers services such as research and development. RF is a cancer research and rehabilitation center provid …
  • Strides Pharma Science Ltd (STAR):企業の財務・戦略的SWOT分析
    Summary Strides Pharma Science Ltd (Strides Pharma), formerly Strides Shasun Ltd, develops and manufactures finished dosage formulations and generic pharmaceutical products. The company operates through pharma, branded generic and institutional business segments. It manufactures soft and hard gelati …
  • Vietnam Dairy Products Joint Stock Co:戦略・SWOT・企業財務分析
    Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Petoro AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Petoro AS (Petoro) is an oil and gas asset management company. The company manages Norwegian state’s direct financial interests (SDFI) in Norwegian Continental Shelf (NCS) oil and gas assets. It has the responsibility for and to attend to the commercial aspects related to the state's direct …
  • Yapi Merkezi Holding Inc.
    Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report Summary Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dohler GmbH:企業の戦略・SWOT・財務分析
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Loral Space & Communications Inc (LORL):企業の財務・戦略的SWOT分析
    Loral Space & Communications Inc (LORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Esselte Corporation:企業の戦略・SWOT・財務分析
    Esselte Corporation - Strategy, SWOT and Corporate Finance Report Summary Esselte Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The Middleby Corporation (MIDD):企業の財務・戦略的SWOT分析
    The Middleby Corporation (MIDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Victrex plc (VCT):企業の財務・戦略的SWOT分析
    Summary Victrex Plc (Victrex) is a chemical company that manufactures and markets high-performance polymer materials and solutions. The company operates through its business units such as Victrex polymer solutions and Invibio biomaterial solutions. Its Victrex polymer solutions unit serves industria …
  • Prysmian S.p.A.:企業のM&A・事業提携・投資動向
    Prysmian S.p.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prysmian S.p.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • SATCO Products Inc:企業の戦略的SWOT分析
    SATCO Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • GoPro, Inc.:戦略・SWOT・企業財務分析
    GoPro, Inc. - Strategy, SWOT and Corporate Finance Report Summary GoPro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Acorn Energy, Inc. (ACFN):石油・ガス:M&Aディール及び事業提携情報
    Summary Acorn Energy Inc (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and comme …
  • Genesis Care Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Genesis Care Pty Ltd (Genesis Care) is a healthcare service provider. The company provides radiation oncology, cardiology and sleep treatment services. It offers radiotherapy, intensity modulated radiotherapy, volumetric arc therapy, stereotactic radiotherapy and radiosurgery, low dose rate …
  • YGM Trading Ltd.:企業の戦略・SWOT・財務情報
    YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary YGM Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • FTI Consulting Inc (FCN):企業の財務・戦略的SWOT分析
    Summary FTI Consulting Inc (FTI) is an independent global consulting service provider. The company offers corporate finance and restructuring, consulting, strategic communications, economic consulting, forensic and litigation, technology and specialty services. It provides it services across various …
  • Pacific World Corporation:企業の戦略・SWOT・財務情報
    Pacific World Corporation - Strategy, SWOT and Corporate Finance Report Summary Pacific World Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆